In contrast, relapsed ALL pediatric patients have been found to have a variety of mutations in N-RAS, KRAS, 5′-nucleotidase, cytosolic II (NT5C2), and phosphoribosyl pyrophosphate synthetase 1 (PRPS1) [26]. Here, NRAS is linked to acute lymphoblastic leukemia.